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ABSTRACT 
 
With the increasing popularity all over the world of Ironman triathlon events, the need to 
determine the type, timing and number of injuries sustained by these triathletes on race day is 
evident. Also to determine the optimum medical staffing requirements and knowledge during 
these events is of importance. 
 
The Ironman South Africa 2011 (IMSA) took place on the 10 of April of that year.  On that 
day 1742 triathletes started the event and a total of 1477 where able to complete the entire 
race distance in the time period allowed, (completion rate of 84.8%).  Of those athletes 
competing, a total of 183 (male 155)(87.4%) and 28 (female)(11.3%) presented to the 
medical facility for treatment.  The mean age of the triathletes presenting was 
38.73(SD±9.82) years and the mean time of presentation to the facility was 12.35(SD±2.33) 
hours after the start of the event.  Injury prevalence showed exercise associated collapse 
(EAC) to be the most common presentation at 44.8%. 
 
The medical support and staffing was established to fit the temporal model of injuries 
sustained by non elite Ironman triathletes.  This allowed increasing medical staffing in the 
latter stages of the race when a greater number of athletes were expected to present for 
medical assistance.    
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CHAPTER 1 – INTRODUCTION 
 
The sport of triathlon is a combination of three specific disciplines, namely that of swimming, 
cycling and running, separated by two transitions which are combined into one singular 
event.
1-3
  Triathlon has seen an exponential growth in popularity since its humble beginnings 
in the late 1970’s.4,5  So much so that it was held as an exhibition sport at the 1992 Barcelona 
Olympic games and then as an Olympic event at the Sydney 2000, Athens 2004, Beijing 2008 
and London 2012 Olympic Games.
1,5
  
 
 At present there are many different distances in which a triathlete  may participate including 
the sprint distance (750m swim, 20km cycle, 5km run), Olympic distance (1,5km swim, 
40km Cycle, 10km run), half Ironman distance (1.9km swim, 90km cycle and 21.1km run) 
and full ironman distance (3.9km swim, 180km cycle, 42.2km run).
1,2,4-8
  However, the Full 
Ironman distance event by its very nature poses some unique ultra endurance challenges to 
the triathlete.
4
  From the first Full Ironman event in Hawaii which was held in 1978 
4,6 
where 
there were 15 starters to the thousands of triathletes who participate around the world in 
various Full Ironman events currently participating.  With this increase and the nature of the 
event, many require medical attention on race day.   There is a need to improve our 
knowledge of the medical conditions that present and the management of these athletes 
during these types of ultra endurance events.
9-11
 Research therefore to better understand the 
types and timing of injuries sustained by these ultra distance triathletes is required.
9
  
 
1.1 Background and brief motivation for this study 
 
With the sport of ultra distance triathlons becoming ever more popular in the world, the need 
for greater understanding of the medical staffing requirements for these athletes during the 
Ironman race day becomes ever more important.  Studies show a much higher rate of severe 
injuries, up to 38.3% and sudden cardiac deaths rates at 1,5 per 100000 in those triathletes 
participating in Ironman distance events.
3,8 
  Current staffing guidelines seem to be 
inadequate during the peak hours of the presenting Ironman triathletes. 
 
2 
 
1.2 Objectives and purpose of this study 
 
The main objectives for the study were to: 
 
a. Describe the types, timing and number of injuries that occurred during the 2011 
Ironman South Africa triathlon event. 
 
b. Evaluate the composition and type of the medical staffing support team providing 
care during the 2011 Ironman South Africa event.  
1.3 Hypothesis 
 
The current composition of the medical team used during the Ironman South Africa triathlon 
event has been inadequate for the type, timing and number of injuries sustained by triathletes 
presenting for medical care during the 2011 Ironman South Africa triathlon event.  
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CHAPTER 2 – LITERATURE REVIEW 
 
2.1 Introduction 
 
Within the expansive field of sports medicine, the medical care for the sport of endurance 
triathlon is now becoming ever more popular.  With the growing popularity of this discipline 
a need for an ever increasing knowledge base about the specific aspects of the sport becomes 
more evident.  This review will attempt to outline the current knowledge within this 
field.
1,3,5,7,12-14
 
 
2.1.1 Background review 
 
The risk of acute injury of the triathlete during a full Ironman triathlon can vary greatly 
between 37% and 91%.
1,3,5,7,12-14
  The types of injuries sustained during these types of events 
may include but are not limited to the following:  Hypothermia, exhaustion, dehydration, 
muscle cramping, heat stroke, hyponatraemia/water intoxication, postural hypotension, 
excessive exposure to ultraviolet radiation, musculoskeletal injuries, minor trauma, bacterial 
infection, gastrointestinal disturbances, sympathetic nervous system exhaustion, haemolysis 
and cardiac complications.
7-11,13,15-23
   
 
The most common condition presenting during Ironman events is dehydration and exercise-
associated collapse, with the prevalence between 50% and 85%.
3,5,25  
This presentation 
increases the risk of electrolyte imbalances and hyponatraemia.
5   
Muscle cramping follows a 
close second(36%).
3
   The incidence of gastrointestinal disturbance in these athletes is 
approximately 30%.
7
   
 
Medical management at Ironman distance triathlon events needs to thus be carefully planned, 
as 85% of athletes requiring treatment present during the final running stage of the event.
7   
It 
has also been shown that athletes needing treatment at the later stages of these events at the 
14hour to 16hour time period required longer stays in the Ironman medical facility for 
management and presented with a higher incidence of acute hyponatraemia.
3
   
 
Current recommendations state that the composition of the medical staffing at each event of 
Ironman triathlon  medical facility should be at a minimum, a race medical director, and 
4 
 
additional physicians at a ratio of one per 200 athletes participating, and nursing staff at a 
ratio of one to every 100 athletes.
7
  Lastly, there should be sufficient massage staff to serve 
the entire race population.
7
   Critically, this staff need to be effectively timed to allow for the 
maximum personnel to avail themselves during the latter times in the event when the demand 
for medical care is at its highest.
3
   
 
Thus, the need for specialised medical personnel is imperative.  Especially more so in the 
case of full Ironman events where the incidence of severe injury was shown to be 38.2% and 
the presentation of other medical conditions at a rate of 37.7%.
3
  This was shown to be a  
higher rate than that of shorter distance triathlons.
3 
 
Therefore, the makeup and skill of the medical team which attends to these unique ultra 
distance triathletes need to be specifically organised and manned with the needs of this 
specific athlete in mind.
3,5,7
  
 
2.2 Endurance associated sport injures  
 
With all sporting disciplines, as with endurance triathlon, certain injuries are more prevalent 
on the race day.  Endurance associated sporting injuries are more common in Ironman 
triathlon due to the extended duration of the event the participants have to endure.
3
  
Described below are the most common injuries presenting for treatment at endurance  
events
.1,3,5,7 
 
2.2.1 Exercise associated collapse (EAC) 
 
By far the most common injury presenting for treatment in Ironman triathlon events was 
exercise associated collapse (EAC) which occurred directly at or soon after crossing the 
finish line of an endurance race.
12,24-31
 The incidence EAC ranges between 17% and 85%  of 
endurance athletes occurring post race depending on the precise definition.
25
   That type of 
condition was caused mostly by postural hypotension and insufficient peripheral 
vasoconstriction occurring during long endurance exercise, worsened by the abrupt stopping 
of activity or exercise at the completion of the event.
24-26
  The presentation of EAC is 
characterised by altered mental state, light headedness, dizziness, fainting and syncope.
25 
 
This condition should be distinctly differentiated from the collapse of an endurance athlete 
5 
 
which occurred during, or on the swim, cycle or run course of an Ironman triathlon event.
24-27  
The latter may present the possibility of a more serious medical condition and in some cases 
may even be life threatening.
24-27,32
 The attending medical staff should also be wary of such 
conditions more serious nature such as cardiac, metabolic or neurological disturbances.
8,24-28
   
 
All of these triathletes who present with EAC require a specific triage algorithm which must 
be performed systematically and methodically by the medical staff manning medical facilities 
at Ironman events.
26
  The evaluation of the patient should include determination of mental 
status as well as site of the collapse.  Secondly, all vital signs should be assessed including, 
heart rate, blood pressure, body temperature, hydration status, serum glucose level and serum 
sodium levels.
24-26
  Once all this information is gathered about the presenting athlete a more 
accurate determination of the diagnosis and severity of the EAC can be established. Athletes 
presenting with this condition were divided into two distinct groups “severe” and “not so 
severe” EAC.24-26  Those with severe EAC symptoms are those in whom the mental state was 
altered, with confusion, disorientation or aggression.  Secondly, it was also present if there 
was a recorded body temperature above or equal to 40
o
C, or with systolic blood pressure less 
than or equal to 100mmHg, or a heart rate above or equal to 100 bpm.  Lastly, when serum 
blood glucose was below 4mmol/L or serum sodium below 135mmol/L or above 
148mmol/L.
24-28
  The less severe group of athletes presenting with this condition were 
classified with having an alert mental status, body temperature less than 40
o
C, systolic blood 
pressure of greater than or equal to 100mmHg, a heart rate of less than 100 bpm, serum blood 
glucose of between 4 – 8 mmol/L and serum sodium of between 135 – 148 mmol/L.24-28    
 
Current treatment consensus guidelines for EAC includes the elevation of the athlete’s legs 
and pelvis by at least 6 inches(±15cm) by lifting the end of the stretcher, the so called 
Trendelenburg position, as well as oral rehydration and intermittent re-evaluation of the 
affected athlete every 15-20 minutes.
24-30
   Most athletes who presented with EAC recovered 
within 15-30 minutes and were able to walk unassisted. The current research review also 
highlighted that the need and use of intravenous (IV) fluids in these athletes was seldom 
warranted as it has not been shown to reduce the discharge time.
29
    
 
2.2.2 Exercise associated hyponatraemia (EAH) 
 
The prevalence of acute hyponatraemia in Ironman triathlon and endurance athletes has been 
6 
 
reported to be between 10% to 75%.
3,5-8,24,33-42   
Hyponatraemia is defined as a serum sodium 
concentration of less than 135mmol/L.
3,5- 8
 
 
However, many triathletes who present with 
serum sodium concentration of between 130 and 135mmol/L present with disorientation or 
even be asymptomatic.
3 5
 
8
  The current literature review attempting to define the exact cause 
of the presentation of EAH was somewhat controversial.
42  
This controversy revolves 
essentially around whether the altered hyponatraemic state presenting in athletes was due to 
electrolyte loss caused by excessive perspiration and dehydration or water intoxication as a 
result of overhydration. 
5,6-8,12,15,26,28 30,33,41-45  
  
 
Rust et al.(2012) described three main factors which are primarily responsible for EAH.  
These include habitual over drinking by the athlete, abnormal secretion of antidiuretic 
hormone (ADH) and the failure of the down regulation of ADH with increasing body fluid 
volume.  Lastly, a lack of mobilisation of Na
+
 from osmotically inactive sodium stores.
33
  
Other studies also showed that in Ironman triathletes who had a vast increase in body weight 
due to fluid overload showed a decrease in serum sodium.
33,45
     
 
2.2.3 Gastrointestinal disturbances  
 
The incidence of gastrointestinal (GI) disturbances of athletes participating in endurance 
events such as Ironman triathlons have been documented between 5% and 59%.
7,8,46-50
  These 
GI disturbances included both the upper and the lower gastro-intestinal tract.
7,8,46-50
  The GI 
complaints included nausea, vomiting, epigastric pain, gastro-oesophageal reflux, generalised 
abdominal pain, diarrhoea and “caecal slap syndromes”.7,8,46-50  Some studies highlight 
certain factors which may worsen or precipitate the presentation of these types of GI 
disturbances.
47
  At increased risk were those athletes who ate a meal less than 30 minutes 
prior to race start, those who ate high fat, high fibre or high protein meals during the event or 
consumed hypertonic beverages.
47
  In one Ironman triathlon event study, which included a 
3.8km sea swim, the incidence of motion sickness and accidental sea water ingestion may 
have  increase the likelihood of  GI symptoms.
7
  Further, the use of non-steroidal anti-
inflammatory drugs (NSAIDS) may also worsen the incidence of GI disturbances due to their 
pharmacological gastric side effects.
7
 
 
 
 
 
7 
 
2.2.4 Heat distress disorders 
 
Athletes competing in an endurance event may present with two extremes of body 
temperature.  A below normal body temperature know as hypothermia and an above normal 
body temperature known as hyperthermia.
25-28
  Normal core body temperature is described in 
the range between 36.1
o
C and 39.4
o
C.
24
  Athletes presenting with symptoms of hypothermia 
have core body temperatures ranging between 36.1
o
C and 32
o
C.
24,27
  Those hypothermic 
athletes should be treated by removing them from the cold environment, removal of all wet 
clothing and warmed by passive measures such as blankets and ingesting warm oral drinking 
fluids.
24 27
  If the athlete does not respond to that treatment evacuation to a hospital 
emergency unit was recommended.
24,27
  
 
On the other extreme, hyperthermia presents as a core body temperature above 39.4
o
C with 
severe cases presenting with core body temperatures above 41.1
o
C.
24,27  
In extreme cases of 
hyperthermia the thermoregulatory system of the body will shut down completely leading to 
a potentially life threatening condition called heatstroke, with temperatures exceeding     
42
o
C. 
24,27 
  In such severe heatstroke rapid intervention is essential with active cooling and 
ice baths to attempt to cool the core body temperature to below 38
o
C.
27
  If the condition is not 
recognised and treated appropriately and rapidly and the core body temperature rises above 
42
o
C the mortality rate of the athlete may rise to as much as 80%.
24,27
  
 
Heat related injury is an important medical risk during any endurance triathlon event such as 
Ironman.  Increased core temperature from intense exercise together with environmental 
conditions such as ambient temperature and humidity combine usually with the run segment 
of the triathlon event at the hottest time of the day.
7
  This is worsened when combined with 
dehydration following the swim and cycle leg, exhaustion and potential hyponatraemia due to 
the slow pace, increased ambient temperature and increased fluid intake during the marathon 
run.
7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
 
2.2.5 Exercise associated muscle cramping 
 
Exercise associated muscle cramping is a painful, spasmodic, involuntary contraction of any 
skeletal muscle directly after the completion of an endurance exercise event.
25-27
  The cause 
of such painful involuntary muscle contractions had initially been attributed to electrolyte 
8 
 
imbalances, hydration, heat stress and glycogen depletion.  However, this assumption was not 
evidence based and subsequent studies show no link between serum electrolyte depletion 
such as sodium or hydration status as a cause of this condition.
25,26,35,36
  More likely are the 
influence of metabolic factors such as acids, pH, ions, proteins and other circulating 
hormones.  Also implicated are prolonged repetitive eccentric muscle activity with connective 
tissue injury as well as fatigue induced neuromuscular activity.
25,26
  Schwellnus et al. (2011) 
described a more scientific basis of the abnormal neuromuscular control.
35
  Showing that as 
muscles fatigue there is an increase in the afferent activity of muscle spindle and a decrease 
in the afferent activity of Golgi tendon organs which in turn may increase alpha motor neuron 
activity.
26,35 
 Although this condition presents frequently it is relatively easily treated with rest 
and passive stretching techniques which maintain the affected muscle group in a lengthened 
position.
25,26
    
 
2.3 Conclusion 
 
The presentation of these endurance associated sporting medical conditions are not unique to 
Ironman triathlon but the medical team on standby at any endurance event should to be 
acutely aware of this type of information.
7
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CHAPTER 3 –MATERIALS AND METHODS 
 
3.1 Ironman South Africa 2011 
 
In the year 2011, the Ironman South Africa (IMSA 2011) event was held on the 10
th
 day of 
April. This event attracted a total of 1742 participants at the start on race day, of which only 
1477 would be able to officially complete the entire ultra distance triathlon event.
51
 Thus, 
showing a completion rate of 84.8% of the race field for the IMSA 2011.  On race day the 
minimum forecast temperature was 10
0
C with a maximum of 23
o
C, a sea temperature of 
20
o
C, relative humidity of 80% with a predicted 10km/h to 20km/h South Easterly wind.
52 
 
During that particular race day a total of 183 triathletes (10.5%) presented for assessment and 
treatment at the IMSA 2011 medical facility.  Of those 183 triathletes presenting, a total of 
155 (87.4%) where male and a total of 28 (15.3%) where female.  The age range of 
presenting athletes was between 20 and 73 years old with a mean age of 38.73 and standard 
deviation of ±9.83 years. 
 
3.2 Medical planning for Ironman South Africa 2011 
 
The medical planning and risk assessment of such a large sporting event is regulated by an 
act of parliament, The Safety at Sports and Recreation Events Act number 2 of 2010 of the 
Republic of South Africa.
53  
This act requires the stringent planning and placement of 
measures as to safeguard persons and property during these types of events.  The health and 
safety at events requirements published by the South African Bureau of Standards must also 
be considered.
54
  To this end the medical planning and risk assessments for the IMSA 2011 
began methodically at least six calendar months prior to the event taking place as required by 
the gazetted legislation.  This medical planning and risk assessment is divided into three 
specific areas namely, aquatic safety, cycle route safety and running route safety.   
Consideration must also be taken for the medical facility layout and staffing requirements and 
positioning. Lastly, all incidents must be co-ordinated though the race and medical directors 
to avoid duplication of orders and poor utilisation of medical resources. 
 
3.2.1 Aquatic safety plan 
 
This leg of the event requires special attention due to the incidence of sudden cardiac deaths 
10 
 
which have been documented in triathlons.
28
  Harris et al. (2010) showed a sudden cardiac 
death rate of 1.5 per 100000 triathlon participants with 93% of the deaths occurring during 
the swim leg of the triathlon.
32 
 Most recently in January 2013 during the Ironman South 
Africa 70.3 half Ironman distance, two sudden cardiac deaths were reported during the swim 
portion of the event.  The planning of the aquatic safety must first consider the required 
length of the Ironman swim distance.  It requires the competitor to complete a 3.8km swim 
course.  During the IMSA event the swim course consists of two 1.9km loops, from the start 
at Hobie beach, Port Elizabeth, South Africa, which the participating Ironman triathlete must 
complete within the 2 hour 20 minute, cut off time limit. (Appendix A)  A second 
consideration is the possible safety risks during the swim leg; these include, but are not 
limited to, shark attack, blue bottle stings, tidal currents and all possible medical conditions 
as described in chapter 2.  Additionally strict compliance to International Triathlon Union 
(ITU) wetsuit regulations was enforced.
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3.2.2 Cycle route safety plan 
 
The cycle route safety plan was also considered around the length of the 180km cycle 
distance.  This entire cycle course was closed to the public and to traffic for the duration of 
the cycle leg.  It consisted of a three loop 60km course which the competing triathlete had to 
complete before the 17h30(10hours and 30minutes) cut off time on race day.  (Appendix B)  
This cycle route was non-draft legal thus requiring the Ironman triathletes to maintain a 10m 
gap both behind and in front of each participant.  Safety considerations include the risk of 
traumatic injury due to falls as well as water table requirements and support vehicles. 
 
3.2.3 Run route safety plan 
 
 The run route safety plan needs to be planned around the 42.2km marathon course run along 
the Marine Drive on Port Elizabeth’s beach front.  Again the run course must be closed to 
traffic and to the public.  Each competitor must complete three loops of the run course to 
finish by the 24h00(17 hours) race cut off time.  (Appendix C)  Consideration of traumatic 
fall injuries, other possible medical conditions and water table availability are paramount.  
This included the placement of water and aid stations at approximately 2km intervals along 
the entire length of the run course.  In addition, an ambulance would continually sweep the 
entire run course and be available to transport any athlete needing medical assistance. 
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3.2.4 Medical facility layout and requirements 
 
The medical facility was set up and laid out according to a specific plan. (Appendix D)         
It included the following: 
- 3 ICU beds with ICU equipment 
- 34 general beds with 1 vital signs monitor per 4 beds 
- 1 blood gas machine 
- 1 ECG and 1 nebulizer 
- 1 O2 cylinder per 4 beds 
- 1 portable defibrillator   
- All drug requirements ( Appendix E) 
- Wound care supplies (Appendix E) 
- Emergency equipment (Appendix E) 
- General medical supplies (Appendix E) 
- Sterile and diagnostic equipment (Appendix E) 
This medical facility was established prior to the beginning of the race day start at 07h00 and 
continued to be available to the end of the race day at 24h00 or until the last triathlete 
requiring treatment had been discharged by the medical team.  In addition, both the Netcare 
Greenacres, and Life St Georges Hospitals were placed on standby for the duration of the 
event day to receive critically ill or injured triathletes referred.   
 
3.2.5 Medical facility staffing requirements 
 
 The staffing of the medical standby facilities at IMSA 2011 were divided into two main 
areas.  Firstly, the main medical facility and a secondary staging area in the bicycle and run 
transition tent area.  In addition to that, three different time shifts were used to divide the 
staffing throughout race day.  Those times were as follows: 
- 05h00-12h00 
- 12h00-16h00 
- 16h00-24h00 
The first time slot from 05h00 to 12h00 was also subdivided into three additional time slots.  
Those times were as follows: 
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- 05h00-07h00 
- 07h00-09h20 
- 09h20-11h30 
The reason for that additional coverage allowed the best medical coverage for the sea swim 
portion during the pre-race warm up and race swim times where there are greater risk of 
injury for the competing triathlete.
32
  The incidence of sudden cardiac death, anaphylaxis due 
to blue bottle or jelly fish stings, simple exhaustion, hypothermia, corneal abrasions and 
swim-induced pulmonary oedema and near drowning must be considered.
28
  During that 
important time during the swim leg, on the beach there was at least 1 advanced trauma life 
support ( ATLS) / advanced cardiac life support (ACLS) trained doctor, 1 advanced life 
support (ALS) paramedic, 8 stretcher bearers and a quad bike available to ferry patients 
across the beach to the medical facility. In addition, in the transition staging area there are, 1 
doctor, 3 nurses and 8 stretcher bearers.  Also during that time there would be no less than 3 
doctors and 9 nursing staff manning the main medical facility to receive injured triathletes 
from the beach and transition areas.  During the 05h00-07h00, 07h00-09h20 and 09h30-
11h30 time slots there were 2 physiotherapists in the transition area and medical facility.   
 
As an extra precaution the entire swim course was covered by life savers, with Jet Ski and 
inflatable rubber duck to supervise the swimming portion of the event and to assist and ferry 
triathletes to the beach if required. (Appendix F) 
 
The second time slot from 12h00-16h00 had the same staffing as for the 05h00 12h00 times 
with the addition of a 1 doctor and 2 physiotherapists in the medical facility. 
 
With the most important time slot from 16h00-24h00 when most of the volume of patients are 
expected, sees a drastic increase in the amount of staffing recruited.
3 7  
During that crucial 
time slot an additional 14 doctors, 20 nurses, 10 Bio-kinetic interns, 16 stretcher bearers and 
4 physiotherapists would join the existing medical team. 
 
In addition to this paramedical staff manning 6 stationary ambulances around the cycle and 
run courses are also at the disposal of the medical facility to ferry patients from around the 
race course to be triaged at the medical tent.  
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It is noted that the medical race director will be on duty from 05h00-24h00 to co-ordinate all 
functions and decisions on race day.  
 
3.2.6 Patient triage protocols 
 
The IMSA protocol dictates every triathlete that presented for treatment at the medical 
facility on race day will be triaged consistently and assessed with the same methodology.  
This will include the determination of mental status in relation to the established Glasgow 
coma scale (Appendix G) as well as all vital signs including heart rate, blood pressure, 
temperature and blood glucose and oxygen saturation.  In addition all demographic data was 
collected as well as medical history and primary presenting complaint recorded.
55
  Only those 
patients who were assessed by the medical staff and found to be metabolically unstable had 
additional blood testing performed.  Blood chemistry measures including pH, partial pressure 
of carbon dioxide (pCo2), partial pressure of oxygen (pO2), serum sodium (Na
+
), serum 
potassium (K
+
), serum glucose, serum lactate (Lac) and Heamatocrit (Hct). 
 
3.2.7  Patient treatment protocols 
 
The treatment protocols established for the use during the Ironman 2011 triathlon event were 
based on already sound published guidelines.
24-31
  These guideline protocols were 
documented and approved by the IMSA medical director, Dr Konrad von Hagen, and the 
Race director Mr Paul Wolf.  All documentation was then made available to all medical staff 
members manning the medical facility at the IMSA 2011 event.   
 
These protocols document algorithms of treatment for the most common injuries which may 
present for treatment on the race day.  These included the following: 
 
- Exercise associated collapse (EAC)  
- Guidelines to determine the severity of the collapsed triathlete 
- Considerations for the initiating of IV fluid therapy 
- Hyperthermia 
- Hypothermia 
- Hyperglycaemia 
- Hypoglycaemia 
14 
 
- Exercise associated muscle cramps 
All of these treatment protocols are shown in detail in appendix H. 
 
3.3 Research Design 
 
A retrospective and descriptive study of the medical data collected from competitors 
presenting for treatment at the Ironman South Africa medical facility in 2011.   
 
This data included demographics, vital signs, presenting injuries or complaints, treatment 
provided, as well as the timing of the presenting triathlete at the medical tent during the entire 
2011 Ironman South Africa Triathlon event.  
 
3.4 Study setting 
 
Ironman South Africa Medical facility, Nelson Mandela Metropolitan Municipality, Port 
Elizabeth. 
 
3.5 Study Population 
 
3.5.1 Sampling, Selection and recruitment of subjects 
 
The study population was the athlete’s participants in the IMSA 2011 event.  The study 
subjects were those participants who presented for medical management on race day. 
 
3.5.2 Inclusion criteria 
 
Only officially registered Ironman South Africa athletes who presented to the medical facility 
who had a valid race number and timing chip were included.  
 
3.5.3 Exclusion criteria 
 
More seriously injured athletes who were transported directly to the standby hospital facility 
were excluded from the study.   
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3.6 Data Collection Procedures 
 
Data were collected by means of a standardised data collection sheet. (Appendix I)  
Athletes presenting for medical care during the events were triaged by trained medical 
personnel.  Once this was completed, athletes were managed medically and information about 
their presenting injury/medical condition, vital signs, course of treatment, duration of stay 
and final discharge was captured on a central database. 
 
3.7 Statistical Analysis 
 
Raw data were captured by support staff attending to the athlete in a Microsoft
®
 Excel
® 
2007 
document for statistical analysis.  The collected data were analysed with the Statistical 
Package for the Social Sciences (SPSS) version 13.0.
56, 57
  The use of descriptive statistics 
was then employed to determine the measures of central tendency i.e.: maximum, minimum, 
range, means, standard deviations, frequencies and percentages of the cohort of triathletes.   
 
These statistical methods were used to describe the type, timing and frequency of the injury 
data collected during the 2011 IMSA.   
 
3.8 Ethics 
 
3.8.1 Ethical approval 
 
Ethical approval was applied for and obtained from the Human Research Ethics Committee 
(medical), University of the Witwatersrand, Johannesburg. Clearance certificate number 
M120964. (Appendix J) 
 
Approval of the topic for the research report was obtained from the School Protocol Review 
Committee and the Faculty Graduate Studies Committee, Faculty of Health Sciences, 
University of the Witwatersrand. (Appendix K) 
 
Permission for the use of the data was obtained from the medical race director for IMSA Dr. 
Konrad von Hagen. (Appendix L) 
 
16 
 
Participation in this study was completely voluntary and anonymous. Participants were 
allowed to withdraw from the study at any time. 
 
3.9 Conclusion 
 
This chapter outlines the material and methods utilised to ethically and accurately complete 
the collection of the required data for this study.  All the participants’ anonymity was 
maintained and the data utilised to perform quantitative research as described in this study.  
These results may be used to give some insight to the appropriate medical staffing and 
management for the IMSA triathlon event taking into consideration the local trends.  
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CHAPTER 4 – RESULTS 
 
4.1 Introduction 
 
This chapter describes the data collected at the IMSA 2011 triathlon event.  The data were 
represented with tables and figures as well as frequency data which will be used to show the 
type, timing and frequency of injuries/medical conditions sustained during this ultra distance 
triathlon race.   
 
4.2 Demographic data description 
  
This describes the distribution of the gender and age of those IMSA 2011 triathletes 
presenting for assessment and treatment during the event. 
 
4.2.1 Gender distribution data 
 
In the cohort of 183 (n=183) triathletes that presented for treatment during the 2011 IMSA 
triathlon event a total of 155 were males (84.7%) and 28 were female (15.3%).(Table 4.1) 
 
TABLE 4.1 – Gender distribution of triathletes presenting for treatment at IMSA 2011 
 
Gender (n) Percentage(%) 
 female 28 15.3 
male 155 84.7 
Total(n) 183 100 
 
 
4.2.2 Ages distribution data 
 
The age range of the183 triathletes was from 20 years old to 73 years old.  The mean age of 
the athletes was 38.73 years old with a standard deviation of ± 9.832.(Table 4.2)(Figure 4.1) 
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TABLE 4.2 – Age distribution of triathletes presenting for treatment at IMSA 2011 
 
Age in years Minimum Maximum Mean 
Std. 
Deviation 
(n=183) 20 73 38.73 ±9.83 
 
Figure 4.1 - Age distribution of triathletes presenting for treatment at IMSA 2011 
 
4.3  Timing and duration data  
  
This data will describe the timing of the triathletes as they presented for treatment and the 
duration of time spent in the medical facility as well as which part of the course they 
presented from. 
 
4.3.1 Presentation of triathletes 
 
The majority of athletes presenting for assessment were directly from the race finish line.  A 
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total of 136 of the 183 patients (74%) presentation from this part of the course.(Table 4.3) 
 
TABLE 4.3 - Description from where IMSA 2011 triathletes presented from.    
 
 (n) Percentage(%) 
 Ambulance 15 8.2 
Massage tent 4 2.2 
Finish line 136 74.3 
Other 24 13.1 
Total 179 97.8 
Missing data 4 2.2 
Total (n=183) 183 100.0 
 
 
 
4.3.2 Timing data of triathletes entering IMSA 2011 medical facility 
 
Triathletes presenting for treatment on race day of IMSA2011 began as early as the first hour.  
Thus, the range of time of athletes presented for treatment was from 1 to 17 hours.  The mean 
time of presentation was 12.35 hours and a standard deviation of± 2.233.(Table 4.4)     
(Figure 4.2)  
 
4.3.3 Timing data of triathletes exiting IMSA 2011 medical facility 
 
Similarly, triathletes exiting the medical facility at IMSA 2011 began in the first hour of the 
race. Therefore, the range is again from 1 to 17 hours.  The mean time presentation of 12.89 
hours and standard deviation of ±2.33.(Table 4.4)(Figure 4.3) 
 
TABLE 4.4 – Timing and duration data of triathletes entering and exiting IMSA 2011 
medical facility 
 
  (N=181) Minimum Maximum Mean 
Std. 
Deviation 
Time into facility 181 1 17 12.35 ±2.23 
Time out of facility 180 1 17 12.89 ±2.33 
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Figure 4.2 – Timing data of triathletes entering IMSA 2011 medical facility 
 
Figure 4.3 - Timing data of triathletes exiting IMSA 2011 medical facility  
 
4.3.4 Duration of stay data for triathletes presenting for treatment during IMSA 2011 
 
Triathletes presenting for treatment during IMSA 2011 had a stay of between 5 and 163 
minutes.  Mean stay was 36 minutes with a standard deviation of ±29.58.(Table 4.5)     
(Figure 4.4) 
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TABLE 4.5 -  Duration of stay data for triathletes presenting for treatment during 
IMSA 2011  
 
  
Minimum Maximum Mean Std. Deviation 
In minutes (n=179) 5 163 36.08 ±29.58 
 
 
 
Figure 4.4 - Duration of stay data for triathletes presenting for treatment during IMSA 
2011 
 
4.4 Vital signs of triathletes presenting for treatment at IMSA 2011 medical facility 
 
Once triathletes presented for treatment at the IMSA 2011 medical facility and triage of the 
patient had taken place all vital signs were documented.  This was completed as per protocol 
and recorded on the prescribed athlete information data collection sheet.  Of the presenting 
athletes it was deemed by the triage doctors that 17 of those patients did not need any further 
interventions and no further data was collected.  Thus, explaining the 17 pieces of missing 
data.  All of this data values, maximums, minimums, means and standard deviations have 
been tabulated. (Table 4.6) 
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4.4.1 Vital signs (Heart rate)(BPM) 
 
Of the 181 triathletes who presented, 164 of those had heart rate measurements completed.  
Not all athletes presenting had vital signs assessed as the attending medical staff deemed it 
unnecessary after the athlete was triaged.  The heart rates recorded were between 51bpm and 
154bpm with a mean of 82.13 bpm and a standard deviation of ±15.394.(Table 4.6) 
 
4.4.2 Vital signs (Blood pressure)(mmHg) 
 
Of the 181 triathletes who presented, 163 of those had blood pressure measurements 
completed.  Those blood pressures measured showed a mean systolic reading of 
164.75mmHg with a standard deviation of ±18.762 and a mean diastolic reading of 
72.34mmHg with a standard deviation of ±11.727.  The systolic blood pressure readings were 
documented between 130mmHg and 198mmHg and the diastolic blood pressure readings 
were documented between 34mmHg and 69mmHg.(Table 4.6) 
 
4.4.3 Vital signs (Temperature)(
o
C) 
 
Of the 181 triathletes who presented, 83 of those had temperature measurements recorded.  
The minimum temperature reading was 34.0
o
C and maximum of 38.2
o
C with a mean of 
36.461
o
C and a standard deviation of ±0.6981.(Table 4.6) 
 
4.4.4 Vital signs (Capillary Blood glucose/ HGT)(mmlo/L) 
 
Of the 181 triathletes who presented, 156 of those had a capillary blood glucose/HGT 
measurement recorded.  The minimum reading was 2.2mmol/L and maximum of 14.2mmol.L 
a mean of 5.527mmol/L and a standard deviation of ±1.4256.(Table 4.6) 
 
4.4.5 Vital signs (Pulse oximetry/Spo2)(%) 
 
Of the 181 triathletes who presented, 78 had of those ha a pulse oximetry SpO2 completed.  
The minimum reading was 93% and the maximum of 100% with a range of 7%, a mean of 
97.93% and a standard deviation of ±1.680.(Table 4.6) 
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4.5 Blood testing/Blood chemistry 
 
Once all basic vital signs had been completed, only those patients whom were not deemed 
metabolically stable by their attending practitioner were then subjected to additional blood 
testing.  This blood testing was completed by qualified medical technologists utilising critical 
care equipment from Instruments Laboratory®.  This was done to exclude any other cause 
which may have worsened the athlete’s medical stability.  Of the 181 triathletes who 
presented for treatment in the IMSA 2011 medical facility, 54 had additional blood tests 
performed.(Table 4.7) 
 
4.5.1 Blood testing (Blood pH) 
 
In the 54 athletes tested pH minimum was 7.33 and maximum 7.74. A mean of 7.4641 and 
standard deviation of ±0.08185.  
 
4.5.2 Blood testing (Partial pressure carbon dioxide/ pCo2)(kPa) 
 
In the 54 athletes tested pCo2 was minimum 2.7 and maximum 7.1. A mean of 4.765 and 
standard deviation of ±0.9713. 
 
4.5.3 Blood testing (Partial pressure oxygen/pO2)(kPa) 
 
In the 54 athletes tested pO2 was a minimum of 2.1 and a maximum of 12.8.  A mean of 
5.167 and standard deviation of ±2.3017. 
 
4.5.4 Blood testing (Blood sodium levels/Na
+
)(mmol/L) 
 
In the 54 athletes tested Na+ levels were minimum of 129.0 and maximum of 143.0.  A mean 
of 136.074 and standard deviation of ±3.2671. 
 
4.5.5 Blood testing (Blood potassium levels/K
+
)(mmol/L) 
 
In the 54 athletes tested minimum K
+
 levels were 3.4 and maximum of 7.2.  A mean of 4.404 
and standard deviation of ±0.7466. 
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4.5.6 Blood testing (Lactate)(mmol/L) 
 
In the 54 athletes tested minimum lactate levels of 0.9 and maximum of 5.3.  A mean of 2.294 
and standard deviation of ±0.9521. 
 
4.5.7 Blood testing (Haematocrit/Hct)(%) 
 
In the 54 athletes tested minimum Hct minimum levels of 31 and maximum of 60.  A mean of 
45.83 and standard deviation of ±5.507. 
 
TABLE 4.6 – Vital signs and blood chemistry of triathletes presenting for treatment at 
IMSA 2011 medical facility 
 
  n (183) Minimum Maximum Mean Std. Deviation 
Heart Rate (Bpm) 164 51 154 82.13 ±15.394 
BP (systolic)(mmHg) 163 130 198 164.75 ±18.762 
BP(diastolic)(mmHg) 163 34 103 72.34 ±11.727 
Temperature (
o
C) 83 34.0 38.2 36.461 ±0.6981 
HGT(mmol/L) 156 2.2 14.2 5.527 ±1.4265 
Spo2(%) 78 93 100 97.73 ±1.680 
pH 54 7.33 7.74 7.4641 ±0.08185 
pCO2(kPa) 54 2.7 7.1 4.765 ±0.9713 
pO2(kPa) 54 2.1 12.8 5.167 ±2.3017 
Na
+
(mmol/L) 54 129.0 143.0 136.074 ±3.2671 
K
+
(mmol/L) 54 3.4 7.2 4.404 ±0.7466 
Lactate(mmol/L) 54 0.9 5.3 2.294 ±0.9521 
Hct(%) 54 31 60 45.83 ±5.507 
Missing data 17 
    
 
4.6 Primary presenting diagnosis/symptoms  
 
In this study cohort (n=183) the most frequent primary diagnosis was that of exercise 
associated collapse (EAC) with 82 occurrences (44%).  This was followed closely by other 
unspecified causes with 33 occurrences (18%) which included mostly blisters, cramping and 
hyperventilation syndrome.  Nausea was the third most common symptom with 27 (14.8%) 
occurrences, fourth was trauma and dehydration with 13 occurrences (7.1%) and the lesser 
hypoglycaemia and hyponatraemia with 5 reports (2.7%) and lastly, hypothermia at 3 
diagnoses (1.6%) respectively.(Table 4.6)(Figure 4.5) 
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TABLE 4.7 – Primary diagnosis/symptoms of triathletes presenting for treatment at the 
IMSA 2011 medical facility 
 
Diagnosis/symptom Frequency Percentage(%) 
 EAC/Postural hypotension 82 44.8 
hypothermia 3 1.6 
hyponatremia 5 2.7 
hypoglycaemia 5 2.7 
dehydration 13 7.1 
trauma 13 7.1 
Nausea 27 14.8 
other 33 18.0 
Total 181 98.9 
 Missing data 2 1.1 
Total                    n=183 183 100.0 
 
 
 
Figure 4.5 - Chart representation of the primary diagnosis/symptoms of triathletes 
presenting for treatment to the IMSA 2011 medical facility 
 
4.6.1 Primary diagnosis/symptoms presentation timing 
 
Of the 183 athletes who presented for treatment between the 9
th
 and the 16
th
 hour of race it is 
evident that the majority were treated for EAC.(Figure 4.6)  
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Figure 4.6 - The number of triathletes presenting during race day and the primary 
diagnosis/symptoms  
 
4.6.2 Primary diagnosis/symptoms and duration of stay 
 
It has been shown in the data that the mean duration of stay of the athlete’s presentation for 
treatment at the IMSA 2011 was 36.08 minutes with standard deviation of ±29.58.  Those 
athletes who were diagnosed with EAH had a longer duration of stay is comparison to the 
other primary diagnosis/symptoms.(Figure 4.7)  What is also evident in those athletes that 
were diagnosed with EAH those with serum Na
+
 below 135 mmol/L had longer mean 
duration of stay in the medical facility before discharge.(Figure4.8) 
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Figure 4.7 -  Mean duration of stay as a function of diagnosis 
 
 
Figure 4.8 - Mean duration of stay as a function of EAH 
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4.6.3 Mean duration of stay as a function of time 
 
During the 9
th
 and 16
th
 hours of the IMSA 2011 race day the mean duration of stay of 36.08 
minutes (SD±29.58) was consistent during those peak hours.   
 
 
Figure 4.9 - Mean duration of stay as a function of Time presentation in to IMSA 2011 
medical facility 
 
4.7 Conclusion 
 
This chapter describes the types, timing and numbers of injuries/medical conditions as well as 
the vital signs of those triathletes that presented at the IMSA 2011 medical facility.  It also 
documented the vital signs and blood chemistry of those athletes who were assessed. 
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CHAPTER 5 – DISCUSSION AND CONCLUSION 
 
5.1 Introduction 
 
This research project from its inception had two main objectives.  These were to firstly, 
accurately describe the type, timing and frequency of injuries presenting for treatment during 
the IMSA 2011 triathlon event.  The second objective was to determine whether the current 
medical planning of staffing for this event was sufficient and if the time placement of that 
staff was in need of being changed.   
 
In the case of an Ironman event special attention needs to be placed on the unique nature of 
this endurance triathlon.  Consideration of the length of the Ironman triathlon total race 
distance of 226.2km and the possible length of time it may take participants to complete the 
event, which may be up to 17 hours in total is of importance.  Also of importance is the 
composition, numbers, ratios of participants to medical staff and specific knowledge of the 
medical team recruited to assist during this type of events.  Furthermore, the number of 
Ironman triathletes that are entered to compete in the event and the potential number of these 
athletes which may present for medical assessment and treatment needs to be determined.  
There is a need for adequate planning for unforeseen contingencies that may occur due to 
extreme environmental conditions.  An additional consideration is the composition of the 
competing Ironman triathletes whom in the vast majority are non-elite competitors.  This 
athlete will require remarkably different needs and treatments in comparison to the from their 
high performance elite counterpart.   
 
5.2 Injury/Medical condition data 
 
During the 2011 IMSA race day a total of 1742 triathletes lined up at the start line.  Of those 
1477 were able to complete the entire swim, cycle and run course within the allotted cut off 
times.  This shows a completion rate of 84.8%.  This rate of completion was fairly consistent 
with the completion rates at other Ironman triathlon events which showed completion rates 
between 80 % and 93%.
5
   
 
Of those 1742 triathletes that started the IMSA 2011 triathlon data showed that 183 
participants, presented for assessment and treatment to the medical facility, a total of 155 
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(87.4%) where male and a total of 28 (15.3%) where female with a mean age of 38.73 years 
old with a standard deviation of ± 9.832.  This represented a treatment presentation rate of 
10.5%.  In comparison with other published literature this was consistent as it also showed a 
2% to 15% treatment presentation rate of Ironman triathletes.
3,5
  The consistency of the 
treatment presentation  data at IMSA 2011 with other studies was encouraging as it closely 
resembles that data that was collected at other international Ironman events and not in South 
Africa.   
 
5.2.1 Timing of injuries presenting 
 
Current literature reports that about 85% of Ironman triathletes presenting for treatment either 
from the run course or from the finishing line of the event.
5,7
  During IMSA 2011 76.4% 
(136) of the triathletes presenting for treatment presented from the finish line and run course. 
With the balance presenting by ambulance (8.2%)(15), from the massage tent (2.2%)(4) and 
other parts of the swim and cycle leg (13.1%)(24).  
 
Most athletes presenting for treatment during IMSA 2011 did so between the 9
th
 and the 16
th 
hour of the race.  The mean time of presentation was 12.35 hours and a standard deviation 
of± 2.233.  This was again consistent with the published literature which also showed the 
similar time distributions.
3,5
  The only consideration is that these publications drew data only 
from the United States of America and not from multiple countries worldwide.  The IMSA 
event is part of the international Ironman calendar of events so it does draw international 
athletes which provide a good demographic in the competing IMSA 2011 field.  
 
During this peak time the overwhelming presentation of EAC was evident.  This high 
incidence is expected as this is a peak time for athletes completing the event.  The data shows 
the overwhelming number of these athletes (74%) present from the finish line. This may also 
be influenced by many factors including environmental and race day weather conditions, 
course structure and swim currents which may be vastly different on each day. 
 
5.2.2 Duration of stay 
 
Some studies have shown that the duration of treatment of Ironman triathletes can be fairly 
long.  Showing mean treatment times as high as 62.3 minutes.
3
  During this study the mean 
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stay of  athletes was shown to be 36.08 minutes with a standard deviation of ±29.58.  Patients 
presenting with diagnosed EAH showed the longest mean duration of stay.  Those triathletes 
who presented with serum Na
+ 
of less than 135 mmol/L had a longer time (160 minutes) to 
discharge from the IMSA 2011 medical facility.  They also required more intensive 
management and repeated observations and additional blood chemistry testing before 
recovery. 
 
5.2.3 Prevalence of injuries 
 
The most common presenting injuries of these athletes was shown in the literature to be EAC, 
EAH, GI disturbances, heat stress disorders and exercise associated muscle cramping.  EAC 
being by far the most common presentation at 44,8% followed by GI disturbances at 14.8% 
and then EAH 2.7%.  When compared to published literature EAC presented with an 
incidence of between 17% and 85%.
12,24-31
  While GI disturbances were documented in 
publications at between 5% and 59%.
7,8,46-50
  EAH  in Ironman triathlon and endurance 
athletes has been reported to be between 10% to 75%.
3,5-8, 24,33-42   
This showing of the IMSA 
2011 data was consistent but with a lower presentation of EAH.  Those IMSA 2011 triathletes 
who presented with EAH also showed a marked increase in the mean duration of stay in the 
medical facility as these athletes were metabolically more unstable. 
 
5.2.4 Vital signs and blood chemistry 
 
In this cohort of IMSA 2011 triathletes measured vital signs were as follows:   
 
Heart rate mean 82.13 bpm ±15.39 SD (51min-154max), systolic blood pressure mean 
164.75mmHg ± 18.76 SD (130min-198max), Diastolic blood pressure mean 72.34mmHg ± 
11.72 SD (34min-103max), HGT(serum glucose) mean 5.52mmol/L ± 1.4 SD (2.2min-
14.2max), body temperature mean 36.46
o
C ± 0.69 SD (34min-38.2max), serum Na
+
 mean 
136.07 mmol/L ± 3.27SD (129min-143max), serum K
+
 mean 4.40 mmol/L ± 0.75 SD 
(3.4min-7.2max) and Hct mean 45.83 % ± 5.50 (31min-60max).   
 
There are many published studies that document the vital sign and blood chemistry of 
Ironman triathletes and the results of those studies are as follows:
29,33,34,36,37  
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Heart rate mean 81-90bpm ± 10-14 SD (60min-102max), systolic blood pressure mean 106-
110 mmHg ± 8-11 SD (89min-130max), diastolic blood pressure mean 67-68mmHg ± 9-10 
SD (48min-80max), HGT mean 5.8-7.6 mmol/L ±0.1-1.5 SD (4.5min-8.9max), body 
temperature mean 35.9-36.1
o
C ±0.5-0.9 SD (34.8min-37.5max), Serum Na
+
 mean 137.2-143 
mmol/L ± 1.5-5SD (135min-147max), serum K
+ 
mean 4.2-4.4 mmol/L ± 0.5-0.6 SD and Hct 
mean 44.3-47.2 % ± 2.4-3.4 SD. 
 
The vital signs and blood chemistry data published in other studies of similar Ironman 
triathletes closely resembles that of data collected at the IMSA 2011.(Table 5.1) 
 
TABLE 5.1 – Vital signs and blood chemistry of IMSA 2011 triathletes in comparison 
with published data  
 
 IMSA 2011 
Mean(±SD) 
Published Data
29,33,34,36,37 
Mean(±SD) 
Heart Rate(Bpm) 82.13(±15.394) 81-90(±10-14) 
Systolic Blood Pressure(mmHg) 164.75(±18.762) 106-110(±8-11) 
Diastolic BloodPressure(mmHg) 72.34(±11.727) 67-68(±9-10) 
Serum Glucose (Hgt)(mmol/L) 5.527(±1.4265) 5.8-7.6(±4.5-8.9) 
Body Temperature(
o
C) 36.461(±0.6981) 35.9-36.1(±0.5-0.9) 
Serum Sodium (Na
+
)(mmol/L) 136.074(±3.2671) 137.2-143(±1.5-5) 
Serum Potassium (K
+
)(mmol/L)  4.404(±0.7466) 4.2-4.4(±0.5-0.6) 
Hct(%) 45.83(±5.507) 44.3-47.2(±2.4-3.4) 
 
 
5.3 Medical staffing requirements 
 
With there being well established medical staffing guidelines for use at Ironman triathlon 
events the current staffing at IMSA 2011 was in line with this.
7
  Considering the timing of 
injury presentation during IMSA 2011 the described medical staffing, which is at its 
maximum between 16h00 and 24h00, allows excellent coverage for the time of presentation 
of the IMSA triathletes.  During this crucial time a total of 20 medical doctors, 32 nurses, 6 
physiotherapists, 10 Bio kinetic interns, 2 podiatrists and 32 stretcher bearers.  During the 
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05h00 to 12h00 midday time slot there would be no less that 5 medical doctors, 12 nurses, 2 
physiotherapists, 2 podiatrists and 16 stretcher bearers.  With the 12h00 to 16h00 being 
staffed by the same number of medical personnel but with the addition of 1 medical doctor 
and 2 physiotherapists.  Current guidelines for the critical period between 16h00 and 24h00 is 
a minimum of 3 doctors, 9 nurses and other paramedical staff per 100 competitors.
3
  Thus 
allowing the best coverage during those times when the volume and duration of treatment of 
athletes are at its highest between the 9
th
 and the 16
th
 hour of the race day. 
 
5.4 Limitations of this study 
 
On completion of this study a few limitations have been noted.  During some of the data 
collection not all of the appropriate information was accurately collected by the attending 
medical staff.  The completion of data collection sheets was in some cases incomplete.  This 
seemed to be worsened during the peak hours of high volume patient presentation.  The peak 
time data losses lead to a problem of missing data in some cases.  In addition 17 of the 
athletes who presented for treatment and assessment had no data collected as they were 
triaged and discharged by the attending doctor due to there being no need for treatment.  
Future research may consider the inclusion of multiple years of data which may help to 
define the value of this data set better.  Also better break down of those many injuries 
described or indicated in the “other” category which made up 18% of the described injuries.  
Many of these patients presentation were not alluded to in detail which may also be seen as a 
short coming of the data presented.   
 
 5.5 Conclusion 
 
In conclusion this study evaluated the type, timing and frequency of injury presentation at the 
IMSA triathlon event and to establish if the current staffing was of sufficient capacity to deal 
with these injuries and medical conditions described.  The results of this study suggest that 
current medical staffing was sufficient and thus rejects a null hypothesis in this case.  Further 
consideration should be given to the environmental conditions which may vary considerably 
from year to year as well as the possibility of larger numbers of competitors and the 
possibility of course route changes in the future IMSA events. An evaluation of medical 
staffing requirements may need to be made annually dependant on the changing 
circumstances. 
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CHAPTER 7 – APPENDIX 
Appendix A 
Ironman South Africa Swim course layout  
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Appendix B 
Ironman South Africa Cycle course layout 
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Appendix C 
Ironman South Africa run course layout 
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Appendix D 
Ironman South Africa medical facility layout 
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Appendix E 
 
Equipment and medical supplies 
 
 Wound care 
 
Adhesive dressings – Various sizes 
     Adhesive tape X 10 
Antiseptic  
Crepe bandages 100mm X 30 
                              50mm X 30 
Elastoplast           75mm X 10 
                              25mm X 10 
Collar and cuff /slings X 10 
Disposable dressing packs X 40 
Eye pads X 10 
Eye kit 
Gauze squares X 10 boxes 
Gloves-non sterile SML  
Local anaesthetic 
                       Xylotox without adrenaline X 20 
                       Xylotox with adrenaline X 10 
Steristrips      X 4 SML 
Stitches           3.0 X 1 box 
                        5.0 X 1 box 
 
Sterile instruments 
 
 Needle holders, Scissors, forceps X 4 
 Scalpel& blades nr. 15 X 4 
 Syringes    20cc X 10 
                       5cc X 1 box 
                       3cc X 1 box 
 Needles       Assorted X 300 
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 Web cols  X 2 boxes 
 
Diagnostic Equipment 
Appendix E continued  
 
 Auroscope X 2 
 Monitor X 10  
 Banometer X 2 
 Opthalmoscope X 2 
 Reflex hammer X 2 
 Stethoscope X 10 
 Thermometers tympanic X 10 
                             Rectal X 2 
 Torch X 10 
 Tongue depressors X 2 boxes 
 Glucometers X 10 
 Blood chemistry analyzer (urea and sodium) X 1 
 Urine specimen bottles X 40 
 Urine dipstix X 1 
 
Emergency equipment 
 
 Airways 2/3/4/5 X 2 
 Magils forceps X 2 
 Jens Gower 
 Introduser 
 Defibrillator/AED X 2 
 ECG monitor, paper X 1 
 ECG electrodes X 400 
 Laryngoscope  X 2 
 Endotracheal tubes X 2 sets 
 Nebulisers X 2 and 20 masks 
 Oxygen cylinders X 10 
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 Oxygen tubing and masks X 40 
 Suction device X 2 and suction catheters nr. 8,12,14 
 Ice packs X 200 
 Ice bath X 1 
 Giving sets(IV) 
Appendix E continued  
 
 Jelcos 
 Butterflies 
 Drip stands 
 
General equipment and supplies 
 
 Blankets X 40 
 Towels X 20 
 Space blanket X 250 
 Bear huggers X 4 
 Beds X 40 
 Tables X 15 
 Medical Cupboard X 1(lockable) 
 Crutches X2 
 Drinks – water/energy/ hot drinks 
 Linen savers X 400 
 Sheets X 100 
 Pillow cases X 50 
 Pillows X 40 
 Black plastic bags 
 Sanitary pads/tampons 
 Sharps boxes X 10 
 Medical waste 
 Stationary  
 White board with markers 
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 Bed numbers 
 Computer and printer & paper 
 Script pad 
 Chairs X 40 
 Clipboards X 40 
 Vomit bowls X 20 
 Fridge  
 Extension cord X 10 
Appendix E continued  
 
 Adapters X 10 
 Patient records X 400 
 Protocols X 10 
 Scale  
 Rubber mats 
 Anti-chafe 
 Sun Screen 
 After Sun 
 Hand Gel 
 
Medication 
 
Injectable: 
 Adrenaline 1:1000 X 30 
 Atropine  X 10 
 Lasics X 10 
 Diazepam 10 mg X 5 
 Hydrocortisone 100mg X 10 
 Lignocaine  2% 5 ml X 4 
 Morphine 10 MG x 5 
 Naloxone X 2 
 Metoclopramide 10mg X 40 
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 Stemetil X 20 
 Akineton X 5 
 Phenergan 25mg X 5 
 Novorapid X 1 
 Scoline 100mg X 2 
 Buscopan 20mg X 20 
 Buscopan Co X 10 
 Nexiam 40mg x 10 
 Adrenacor 6 mg X10 
 Cardorone 150 mg x 5 
 Dormicum 5mg/5ml X 5 
Appendix E continued  
 
 Pavilon 4mg X 4 
 Aminophylline X 10 
 Zofran X 20 
 Tramahexal X 20 
 Magnesium sulphate 50% 10 X 2ml ampules 
 
Oral 
 
 Analgesics – Ibupain 30 X 3 
                       -  Ibupain forte X 3 
                            - Paracetemol X 100 
                            - Panado syrup 2X 100ml 
                            - Tramacet X 30 
 Anti-emetics Clopamon 10mg X 30 
                           Mitil 5mg X 30  
                           Zofran X 10 
 Ativan 1mg Subligual X 10 
 GTN sublingual spray X 1 
 Disprin CV X 1box 
 Gaviscon  advance 200ml X 2 
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Appendix E continued  
 Gaviscon tabs X 20 
 Isordil 5 mg S/l X 10 
 Deselex X 60 
 Buscopan X 20 
 Buscopan Co X 60 
 Celestamine X 30 
 Corenza C X 20 
 
Inhaled 
  
 Duolin X 20 
 Pulmicort 0.5mg/ml X 10 
 
Topical 
 
 Fluoroscein X 4 
 Novocin wonder X 2 
 Chloromycetin eye ointment X 10 
 Bactroban 15g X  5 
 Elmetasin spray X 2 
 
IV Fluids 
 
 5% Dextrose 1L X 12 
 50% Dextrose 50ml X 6 
 Ringers 1L X 12 boxes 
 3-5% NaCL X 5 
 Sodium bicarbonate 8,5% 50ml X 2 
 Calcium glugonate X 2 
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Appendix F 
Ironman swim course staff deployment 
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Appendix G 
 
Glasgow coma scale 
55
 
 
Eye opening: 
4 Spontaneous 
3 To voice 
2 To pain 
1   None    
Verbal response: 
5 Orientated 
4 Confused 
3 Inappropriate words 
2 Incomprehensible 
1 None                   
Motor response: 
6 Obeys command 
5 Localises pain 
4 Withdraws to pain 
3 Flexion to pain 
2 Extension to pain 
1 None                       
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Appendix H 
Ironman South Africa 2011Treatment Protocols 
Exercise associated collapse 
 
 
EXERSICE ASSOCIATED 
COLLAPSE 
DURING OR AFTER EVENT 
 
CONSCIOUS   NO  ACLS 
 
 
YES 
 
 ALTERED CONSCIOUSNESS 
 
 
YES  
      
-Vital signs      
- Elevate pelvis and legs 
- Sodium, Glucose. Urea 
- Consider IV fluids 
- Treat abnormal findings 
- See appropriate protocols 
      NO 
      -Vital signs 
- Oral rehydration 
- Elevate pelvis and legs 
    
ASSESMENT 
 
   NOT SEVERE SEVERE 
 
MENTAL STATE 
 
 
CONSCIOUS 
ALERT 
 
UNCONSCIOUS 
CONFUSED, 
DISORIANTATED 
 
RECTAL 
TEMPERATURE 
 
 
34-36°C ( 93,2-96,8°F) 
 
 
>40°C ( 104°F) 
      < 34°C ( 93,2°F) 
 
SYSTOLIC BLOOD 
PRESSURE 
 
 
> 100mmHG 
 
< 100mmHG 
HEART RATE 
 
< 100bpm > 100bpm 
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BLOOD GLUCOSE 
 
4-10 mmol/L < 4mmol/L > 12mmol/L 
SERUM SODIUM 
 
135-148mmol/L < 135mmol/L OR 
>148mmol/L 
BODY WEIGHT LOSS 
 
0-5% > 10% 
BODY WEIGHT GAIN 
 
< 2% > 2% 
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Appendix H 
Treatment Protocols 
Exercise associated collapse continued 
 
 
      REASSESS 
 
 
    SEVERE SYMPTOMS              NON SEVERE   
 
         
APPROPRIATE TREATMENT 
 
TRANSFER TO HOSPITAL    NOT STABLE 
 
 
      
         
              OBSERVE 
              DISCHARGE IF  
           STABLE 
             
Considerations for initiation of IV therapy 
 
Consider IV fluid therapy if patient has: 
 
o Obvious signs of dehydration     - sunken eyes 
                                                             - parched lips and tongue 
                                               - poor skin turgor 
 
o Persistent tachycardia   ( heart rate > 100 bpm) 
 
o Persistent hypotension    ( systolic BP < 110mmhg) 
 
Initiate IV fluid therapy if: 
 
o Hemodynamic instability – symptomatic tachycardia or bradycardia. 
o Arrhythmia or cardiac ischaemia on ECG 
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Appendix H 
Treatment Protocols continued 
Guidelines to determine the severity of a collapsed athlete 
 
ASSESMENT 
 
   NOT SEVERE SEVERE 
 
MENTAL STATE 
 
 
CONSCIOUS 
ALERT 
 
UNCONSCIOUS 
CONFUSED, 
DISORIANTATED 
 
RECTAL 
TEMPERATURE 
 
 
34-36°C ( 93,2-96,8°F) 
 
 
>40°C ( 104°F) 
      < 34°C ( 93,2°F) 
 
SYSTOLIC BLOOD 
PRESSURE 
 
 
> 100mmHG 
 
< 100mmHG 
HEART RATE 
 
< 100bpm > 100bpm 
BLOOD GLUCOSE 
 
4-10 mmol/L < 4mmol/L > 12mmol/L 
SERUM SODIUM 
 
135-148mmol/L < 135mmol/L OR 
>148mmol/L 
BODY WEIGHT LOSS 
 
0-5% > 10% 
BODY WEIGHT GAIN < 2% > 2% 
 
 
 
                        HYPERTHERMIA 
 
 
    - RECTAL TEMPERATURE > 40°C ( 104°F ) 
                             & 
     - ALTERED MENTAL STATUS 
 
 
 
- IMMERSE ATHLETE IN ICE WATER FOR 5-10 MINUTES 
        -    THE TEMP SHOULD REDUCE WITHIN 10 MIN TO 38°C (100,4°F ) 
- TREAT DEHYDRATION IF PRESENT 
   (  CHECK SERUM SODIUM FIRST ) 
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Appendix H 
Treatment Protocols continued 
      
HYPOTHERMIA 
 
      SEVERE     
TEMP < 30°C (86°F ) 
          MODERATE 
TEMP 30°- 34°C 
          ( 86-93,2°F ) 
                   MILD 
TEMP 34-36°C 
                  ( 93,2- 96,8°F) 
   
          
REMOVE WET CLOTHING 
BLANKET 
WARM FLUIDS ORAL/IV 
        REMOVE WET CLOTHING 
BLANKET 
WARM FLUIDS ORALLY 
 
 
        TRANSFER 
      TO HOSPITAL 
 
 
                HYPOGLYCAEMIA 
 
       
     CONSCIOUS 
 
    YES         NO 
 
 
          
      ORAL GLUCOSE     IV 50 % DEXTROSE 
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Appendix H 
Treatment Protocols continued 
 
 
MUSCLE CRAMPING 
 
 
o STRETCH THE MUSCLE 
o MASSAGE  
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Appendix I 
Standardised data collection form. 
Ironman South Africa Medical Record 2011 
                                 IRONMAN MEDICAL RECORD 2011 
 
TIME IN                                                                                                                                 
TIME OUT 
Anonymous Athlete Reference number:_____________   AGE:            .                                                        
SEX: M         F                  MEDICAL HISTORY:                                                  
ALLERGIES:          
________________________________________________________________________ 
RACE INFORMATION:                 
ARRIVED FROM:  Ambulance  Massage    Finish Line  Other                                                                                                                                                                               
MEDICATION:                                                                                                                                              
.                                                                                                                         
(Before and during race) 
RECENT ILLNESS:      YES             NO               
________________________________________________________________________ 
MAIN COMPLAINT: 
 Confusion         Seizures  Exhaustion  Short of Breath 
 Vomiting  Diarrhoea       Abd Cramps  Muscle Cramps                    
 Dizziness     Syncope  Nausea  Headache  
 Trauma              Other 
________________________________________________________________________ 
CLINICAL FINDINGS/ VITAL SIGNS: 
MENTAL STATUS:   ALERT       VERBAL RESPONSE        PAIN          
UNRESPONSIVE   
TIME:                       PULSE:     BP supine          BP Sitting           TEMP:                 HGT:               
U&E 
                  
                  
                  
                  
                  
                  
 
DIAGNOSIS:  
EAC/ POSTURAL HYPOTENSION  HYPOGLYCAEMIA  
HYPERTHERMIA  DEHYDRATION  
HYPOTHERMIA  TRAUMA  
HYPONATREMIA  OTHER  
 
TREATMENT:……………………………………….………………………………………
DISCHARGE NOTE: …………………………………………………………………… 
Athlete seen by: 
 DOCTOR                     
NURSE__________PHYSIOTHERAPIST_________OTHER_______                                      
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Appendix J 
 
Ethics clearance certificate. 
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Appendix K 
Approval of title letter  
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Appendix L 
 
Letter of permission from Ironman South Africa Medical Race Director. 
 
 
Intercare Port Elizabeth         
Cnr of Buffelsfontein and Titian Roads, Walmer, Port Elizabeth 
Tel.  (041) 395 9620  
      
 
 
14 August 2012 
 
To whom it may Concern, 
 
This letter serves to confirm that I give permission for the use of medical data obtained from 
athletes who participated in Ironman South Africa for the year 2011 to be used for the 
purpose of  a research study to be conducted by Stuart Alexander (Student number : 331757). 
 
Yours faithfully 
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